Beta společnosti Novabay Pharmaceuticals Inc
Jaká je hodnota metriky Beta společnosti Novabay Pharmaceuticals Inc?
Hodnota metriky Beta společnosti Novabay Pharmaceuticals Inc je 0.00
Jaká je definice metriky Beta?
BETA koeficient vyjadřuje, zda je akcie více či méně volatilní než trh jako celek. Beta menší než 1 znamená, že akcie jsou méně volatilní než trh, zatímco beta větší než 1 znamená, že akcie jsou volatilnější. Volatilita se měří pomocí fluktuace ceny akcie.
Beta is a measure of the risk arising from exposure to general market movements as opposed to idiosyncratic factors. The market portfolio of all investable assets has a beta of exactly 1. A beta below 1 can indicate either an investment with lower volatility than the market, or a volatile investment whose price movements are not highly correlated with the market. A beta greater than one generally means that the asset both is volatile and tends to move up and down with the market. Beta is important because it measures the risk of an investment that cannot be reduced by diversification. It does not measure the risk of an investment held on a stand-alone basis, but the amount of risk the investment adds to an already-diversified portfolio. In the capital asset pricing model, beta risk is the only kind of risk for which investors should receive an expected return higher than the risk-free rate of interest.
Beta společností v sektoru Health Care sektor na NYSEMKT ve srovnání se společností Novabay Pharmaceuticals Inc
Čemu se věnuje společnost Novabay Pharmaceuticals Inc?
novabay pharmaceuticals $nby is a biopharmaceutical company focusing, commercializing and developing its non-antibiotic anti-infective products to address the unmet therapeutic needs of the global eye care market. novabay has two distinct product categories: the neutrox™ family of products, led by avenova™ for the eye care market, neutrophase® for wound care, and cellerx™ for the dermatology market; and aganocide® compounds, led by auriclosene™. novabay is commercializing avenova, a prescription lid and lash hygiene product for the management of the chronic eye conditions of blepharitis and meibomian gland dysfunction – also known as dry eye syndrome. these difficult-to-manage conditions affect approximately 30 million americans, with an annual market potential that novabay estimates at $500 million. novabay is gaining market traction with avenova through its 35-medical direct sales representatives under veteran leadership. avenova is available for order in 90% of all pharmacies across
Firmy s metrikou beta podobnou společnosti Novabay Pharmaceuticals Inc
- Hodnota metriky Beta společnosti Vision Marine Technologies je 0.00
- Hodnota metriky Beta společnosti Ely Gold Royalties je 0.00
- Hodnota metriky Beta společnosti Glacier Lake Resources je 0.00
- Hodnota metriky Beta společnosti Magnum Mining and Exploration je 0.00
- Hodnota metriky Beta společnosti Africa Opportunity Fund je 0.00
- Hodnota metriky Beta společnosti Fulcrum Utility Services je 0.00
- Hodnota metriky Beta společnosti Novabay Pharmaceuticals Inc je 0.00
- Hodnota metriky Beta společnosti Gullewa je 0.00
- Hodnota metriky Beta společnosti S.A.L. Steel je 0.00
- Hodnota metriky Beta společnosti Andina Acquisition III je 0.00
- Hodnota metriky Beta společnosti Andina Acquisition III je 0.00
- Hodnota metriky Beta společnosti Brilliant Acquisition je 0.00
- Hodnota metriky Beta společnosti Indokem je 0.00